REVATIO for Cardiac disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where REVATIO was used for Cardiac disorder.
Most Reported Side Effects for REVATIO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 79 | 18.2% | 79 | 3 |
| Pulmonary hypertension | 44 | 10.1% | 39 | 10 |
| Dyspnoea | 41 | 9.5% | 6 | 14 |
| Cardiac failure | 26 | 6.0% | 19 | 6 |
| Fall | 21 | 4.8% | 2 | 10 |
| Pneumonia | 20 | 4.6% | 10 | 9 |
| Malaise | 17 | 3.9% | 1 | 6 |
| Cardiac disorder | 14 | 3.2% | 6 | 3 |
| Respiratory failure | 13 | 3.0% | 13 | 4 |
| Fluid retention | 11 | 2.5% | 1 | 10 |
| Hypotension | 10 | 2.3% | 4 | 6 |
| Off label use | 10 | 2.3% | 5 | 2 |
| Chronic obstructive pulmonary disease | 9 | 2.1% | 5 | 1 |
| Myocardial infarction | 9 | 2.1% | 5 | 1 |
| Cardiac failure congestive | 8 | 1.8% | 7 | 3 |
Other Indications for REVATIO
Pulmonary hypertension (153)
Pulmonary arterial hypertension (111)
Product used for unknown indication (8)
Other Drugs Used for Cardiac disorder
ASPIRIN (1,085)
EVOLOCUMAB (910)
SACUBITRIL\VALSARTAN (907)
METOPROLOL (717)
CLOPIDOGREL BISULFATE (330)
CARVEDILOL (284)
RIVAROXABAN (280)
AMIODARONE (256)
TAFAMIDIS (255)
ATORVASTATIN (250)